Artivion, Inc.
Artivion, Inc., formerly known as Aortech International, is a leading medical technology company headquartered in the United States. Founded in 2000, Artivion has established itself in the cardiovascular industry, focusing on innovative solutions for cardiac and vascular surgery. The company is renowned for its advanced bioengineered products, including the Aorfix™ stent graft, which offers unique features for treating aortic aneurysms. With a strong presence in North America and expanding operations in Europe and Asia, Artivion is committed to enhancing patient outcomes through its cutting-edge technologies. The company has achieved significant milestones, including regulatory approvals and partnerships that bolster its market position. Artivion continues to be recognised for its dedication to innovation and quality in the medical device sector, making it a trusted name among healthcare professionals worldwide.
DitchCarbon Score
How does Artivion, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Artivion, Inc.'s score of 25 is lower than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Artivion, Inc.'s reported carbon emissions
In 2021, Artivion, Inc. reported total carbon emissions of approximately 6,116,000 kg CO2e, comprising 5,051,000 kg CO2e from Scope 1, 558,000 kg CO2e from Scope 2, and 1,051,000 kg CO2e from Scope 3 emissions. The company has not disclosed any specific reduction targets or initiatives under the Science Based Targets initiative (SBTi) or other climate pledges. Artivion's emissions data reflects its operational impact, with the majority stemming from direct operations (Scope 1) and energy consumption (Scope 2). The absence of formal reduction commitments indicates a potential area for future focus as the company navigates the growing emphasis on sustainability within the medical technology industry.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | |
|---|---|
| Scope 1 | 5,051,000 |
| Scope 2 | 558,000 |
| Scope 3 | 1,051,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Artivion, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
